Full Coverage
U.S. backs waiving patent protections for Covid vaccines, citing global health crisis
By Thomas Franck, Kevin Breuninger & Amanda Macias
Top news
WHO Director-General commends United States decision to support temporary waiver on intellectual property rights for ...
Stopping Drug Patents Has Stopped Pandemics Before
By Laurie Garrett
All you need to know about the battle over COVID jab IP rights
By Virginia Pietromarchi
Biden administration to waive vaccine patent protection - The Washington Post
By Dan Diamond, Tyler Pager & Jeff Stein
All coverage
Industry fights over global vaccine patents are just warming up
By Christopher Rowland
Angela Merkel rejects US move to waive patents on vaccines
By Guy Chazan, Hannah Kuchler & Jim Brunsden
Explainer: COVID-19 vaccine patents dominate global trade talks
By Philip Blenkinsop
Biden Backs Waiving International Patent Protections For COVID-19 Vaccines
By Emma Bowman & Ashish Valentine
Explained: Intellectual property waiver for Covid-19 vaccines
By Aanchal Magazine & Prabha Raghavan
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive
By Helen Branswell, Matthew Herper & Damian Garde
Covid: The vaccine patent row explained
By Dharshini David
Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
By Madeline Chambers, Douglas Busvine & Andreas Rinke
U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents
By Jeff Mason, Andrea Shalal-Esa & David Lawder
TRIPS waiver: there's more to the story than vaccine patents
By Hyo Yoon Kang, Siva Thambisetty & Jocelyn Bosse